Skip to content
777 Sourcing.

Capability

small molecule inhibitor development

Suppliers
2
States & provinces
2
Countries
1

2 small molecule inhibitor development suppliers across 2 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

ABLI THERAPEUTICS INC

ATLANTA, GA

ABLi Therapeutics, Inc. develops innovative treatments for Parkinson's disease and other neurodegenerative disorders by targeting non-receptor Abelson Tyrosine Kinases (Abl kinases or c-Abl) with small molecule inhibitors. Its proprietary Re-engineering Approach with Metabolism Preserved (RAMP™) drug innovation engine uses clinically validated kinase inhibitor data to design novel product candidates with enhanced brain penetration, potentially higher potency and improved safety.

drug innovation/developmentkinase inhibitor engineering

Compiled from public sources

EPIVARIO INC

PHILADELPHIA, PA

EpiVario Inc. is an innovation-focused biotechnology company spun out of the Epigenetics Institute of the University of Pennsylvania. It develops neuroepigenetic modulators and pharmacotherapeutics targeting a newly discovered epigenetic process in long-term memory, aiming to treat memory-related addiction and psychiatric disorders including PTSD, opioid use disorder, alcohol use disorder, and nicotine use disorder. Its cofounders discovered the metabolic enzyme ACSS2, and the company is developing a proprietary small molecule inhibitor of ACSS2.

drug developmentepigenetic therapeutics research

Compiled from public sources

Related capabilities

Other processes offered by the shops that list small molecule inhibitor development.

Browse all capabilities